中风管理市场规模、份额、成长分析，按类型、按产品、最终用户、按地区 - 行业预测，2024-2031 年

2022年全球卒中管理市场规模为366亿美元，从2023年的393.8亿美元增长到2031年的707.6亿美元，在预测期内（2024-2031年）预计复合年增长率为7.6%。

在人口快速老化、医疗技术进步以及诊断和治疗方法增强的推动下，全球中风管理市场正在经历显着增长。远端医疗和数位健康解决方案的整合正在改善中风治疗的可近性，同时强调预防策略和综合復健计划。市场上的主要企业正在血栓移除设备、神经保护剂和个人化治疗方法等领域进行创新。然而，挑战依然存在，包括中风治疗的可近性和意识存在差异，特别是在发展中地区。市场正在朝着以患者为中心的综合护理模式发展，并得到旨在改善结果和减少中风长期影响的持续研究的支持。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析

中风管理市场规模：按类型和复合年增长率（2024-2031）

• 市场概况
• 缺血性的
• 出血性的
• 短暂性脑缺血发作（TIA）
• 其他的

中风管理市场规模：依产品及复合年增长率（2024-2031）

• 市场概况
• 诊断设备
  • 磁振造影(MRI)
  • 电脑断层扫描（电脑断层扫描）
  • 心电图测试
  • 颈动脉超音波检查
  • 脑血管血管造影术
  • 其他的
• 治疗设备
  • 支架回收器
  • 手术夹
  • 栓塞弹簧圈
  • 分流器
  • 吸引导管
  • 其他的

中风管理市场规模：依最终用户和复合年增长率（2024-2031）

• 市场概况
• 医院
• 诊断诊所
• 门诊手术中心
• 其他的

中风管理市场规模：按地区及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Medtronic
• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Boston Scientific Corporation
• Abbott Laboratories
• Johnson & Johnson
• Penumbra, Inc.
• Stryker Corporation
• Boehringer Ingelheim
• AstraZeneca
• Pfizer Inc.
• Sanofi
• Bayer AG
• Daiichi Sankyo Company, Limited
• F. Hoffmann-La Roche Ltd
• Teva Pharmaceuticals
• Lupin Pharmaceuticals
• Fresenius SE & Co. KGaA
• Amneal Pharmaceuticals LLC

结论和建议

Global Stroke Management Market size was valued at USD 36.6 billion in 2022 and is poised to grow from USD 39.38 billion in 2023 to USD 70.76 billion by 2031, growing at a CAGR of 7.6% during the forecast period (2024-2031).

The global stroke management market is witnessing significant growth, propelled by advancements in medical technology and enhanced diagnosis and treatment methods, alongside a rapidly aging population. The integration of telemedicine and digital health solutions is improving access to stroke care, while there is a strong emphasis on preventive strategies and comprehensive rehabilitation programs. Key market players are innovating in areas such as clot retrieval devices, neuroprotective agents, and personalized treatment approaches. Nonetheless, challenges persist, particularly regarding disparities in stroke care access and awareness in developing regions. The market is evolving towards integrated, patient-centric care models, supported by ongoing research aimed at improving outcomes and reducing long-term effects of strokes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stroke Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stroke Management Market Segmental Analysis

Global Stroke Management Market is segmented by type, product, end user and region. Based on type, the market is segmented into ischemic, hemorrhagic, transient ischemic attack (TIA) and others. Based on product, the market is segmented into diagnostic devices and therapeutic devices. Based on end user, the market is segmented into hospitals, diagnostic clinics, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Stroke Management Market

The global stroke management market is experiencing significant growth driven by several key factors. One of the primary catalysts is the rising investment in healthcare infrastructure, which supports the implementation of cutting-edge technologies and telemedicine solutions. These advancements facilitate earlier diagnoses and more effective treatment options, significantly enhancing the quality of care provided to stroke patients. As healthcare systems evolve and prioritize these innovative approaches, patient outcomes are improved, leading to a greater demand for comprehensive stroke management solutions. Consequently, the market is expected to expand as healthcare providers increasingly adopt these transformative tools to optimize patient care.

Restraints in the Global Stroke Management Market

The global stroke management market faces several significant restraints that impede its growth potential. A notable barrier is the lack of accessibility to effective stroke care, particularly in underserved regions where awareness of stroke symptoms and treatment options remains low. Additionally, the high cost of treatment poses a financial challenge for many patients, further limiting their access to necessary interventions. Moreover, the integration of advanced stroke management technologies within existing healthcare systems often encounters obstacles, preventing seamless implementation and optimal utilization. These factors collectively hinder the advancement and expansion of stroke management solutions on a global scale.

Market Trends of the Global Stroke Management Market

The global stroke management market is experiencing significant growth, driven by technological advancements and increased awareness. Telemedicine and digital health innovations facilitate timely remote monitoring and intervention, drastically improving patient care. Enhanced neuroimaging techniques, like MRI and CT scans, provide precise diagnoses, allowing for more accurate treatment plans. Minimally invasive surgical options, particularly endovascular thrombectomy, are transforming acute management strategies. Additionally, breakthroughs in pharmaceuticals have introduced more effective thrombolytics and neuroprotective agents. Collaborative research initiatives and heightened public awareness around early intervention and risk factor management underscore a concerted effort to enhance prevention, acute treatment, and rehabilitation, ultimately aiming to reduce the global burden of stroke.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Stroke Management Market Size by Type & CAGR (2024-2031)

• Market Overview
• Ischemic
• Hemorrhagic
• Transient Ischemic Attack (TIA)
• Others

Global Stroke Management Market Size by Product & CAGR (2024-2031)

• Market Overview
• Diagnostic Devices
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography Scan (CT scan)
  • Electrocardiography
  • Carotid Ultrasound
  • Cerebral Angiography
  • Others
• Therapeutic Devices
  • Stent Retriever
  • Surgical Clips
  • Embolic Coils
  • Flow Diverters
  • Aspiration Catheters
  • Others

Global Stroke Management Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Diagnostic Clinics
• Ambulatory Surgery Centers
• Others

Global Stroke Management Market Size & CAGR (2024-2031)

• North America (Type, Product, End User)
  • USA
  • Canada
• Europe (Type, Product, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daiichi Sankyo Company, Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amneal Pharmaceuticals LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations